HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer
Conditions
- Cervical Cancer
- Head and Neck Squamous Cell Carcinoma
Interventions
- DRUG: HPV E6-specific TCR-T cells
Sponsor
Xinqiao Hospital of Chongqing
Collaborators